Let’s take a look at Atomos’ cloud-based web editor and see what it offers for your video workflows.
OpenAI and Paradigm have released EVMbench—a framework for evaluating AI agents' ability to find vulnerabilities in Ethereum smart contracts.
The unified JavaScript runtime standard is an idea whose time has come. Here’s an inside look at the movement for server-side JavaScript interoperability.
OpenAI and Paradigm launched EVMbench, a tool that tests how capable AI agents are at finding and fixing smart contract vulnerabilities.
(“Infleqtion”), a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced the completion of its previously announced business combination with ...
LOS GATOS, CA / / February 12, 2026 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results ...
Churchill Capital Corp X (“Churchill X”) (NASDAQ: CCCX), a publicly traded special purpose acquisition company, today announced that its shareholders have approved the previously announced business ...
Yet if the industry gets better at incorporating technology throughout the process, from the initial enquiry to completion, we can ensure borrowers enjoy a ...
Most of us take hearing for granted, but not everyone enjoys that privilege. Conversations start to feel like guessing games, laughter seems far away, and the soft background sounds that make life ...
Crowdcube is now allowing retail investors to acquire shares in Atom Bank. The UK based fintech firm is the latest in what has become a long line of startup initiatives that Crowdcube has enabled ...
Cold atom experiments are among the most powerful and precise ways of investigating and measuring the Universe and exploring the quantum world. By trapping atoms and exploiting their quantum ...
Atom Therapeutics is touting data from a phase 2b/3 study as evidence that its gout drug has the efficacy and safety profile to stand out from the competition. The Chinese biotech evaluated the oral ...